SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes [0.03%]
无糖尿病患者的钠-葡萄糖协同转运蛋白2抑制剂所致酮症酸中毒
Annabelle G Hayes,Lisa M Raven,Alexander Viardot et al.
Annabelle G Hayes et al.
Case Reports
Diabetes care. 2024 Jan 1;47(1):e4-e5. DOI:10.2337/dc23-1903 2024
Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial [0.03%]
睡眠限制独立于肥胖变化损害女性胰岛素敏感性：一项随机对照试验的结果
Faris M Zuraikat,Blandine Laferrère,Bin Cheng et al.
Faris M Zuraikat et al.
Objective: Insufficient sleep is associated with type 2 diabetes, yet the causal impact of chronic insufficient sleep on glucose metabolism in women is unknown. We investigated whether prolonged mild sleep restriction (SR...
Randomized Controlled Trial
Diabetes care. 2024 Jan 1;47(1):117-125. DOI:10.2337/dc23-1156 2024
Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among American Indian and Alaska Native Peoples in 2012-2013 [0.03%]
2012-2013年美国美洲原住民和阿拉斯加土著居民中诊断的1型糖尿病和2型糖尿病患病率
Jiahui Dai,Xiaoyi Niu,Ann Bullock et al.
Jiahui Dai et al.
Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal [0.03%]
二甲双胍与西咪替丁相互作用及肾功能衰竭患者的乳酸酸中毒风险：药物警戒-药代动力学评估
Wenhuo Xie,Jianbin Li,Chenghua Kong et al.
Wenhuo Xie et al.
Objective: This study aimed to evaluate lactic acidosis (LA) risk when using metformin combined with histamine H2 receptor inhibitors (H2RI) in patients with renal failure (RF). ...
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting [0.03%]
一项前瞻性多中心研究：评估两种先进的混合闭环系统在真实世界环境中的血糖控制及患者报告结果的改善作用
Pilar Isabel Beato-Víbora,Ana Chico,Jesus Moreno-Fernandez et al.
Pilar Isabel Beato-Víbora et al.
Objective: Advanced hybrid closed-loop systems (AHCL) have been shown to improve glycemic control and patient-reported outcomes in type 1 diabetes. The aim was to analyze the outcomes of two commercially available AHCL in...
Multicenter Study
Diabetes care. 2024 Feb 1;47(2):216-224. DOI:10.2337/dc23-1355 2024
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial [0.03%]
玛 Zucker 维素在治疗 2 型糖尿病患者的有效性和安全性：一项随机、双盲、安慰剂对照的 II 期临床试验
Bo Zhang,Zhifeng Cheng,Ji Chen et al.
Bo Zhang et al.
Objective: We conducted a randomized, double-blind, placebo-controlled phase 2 trial to evaluate the efficacy and safety of mazdutide, a once-weekly glucagon-like peptide 1 and glucagon receptor dual agonist, in Chinese p...
Clinical Trial
Diabetes care. 2024 Jan 1;47(1):160-168. DOI:10.2337/dc23-1287 2024
The Acute Effects of Real-World Physical Activity on Glycemia in Adolescents With Type 1 Diabetes: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study [0.03%]
真实世界体育活动对1型糖尿病青少年血糖的急性影响：1型糖尿病运动计划儿科(T1DEXIP)研究
Michael C Riddell,Robin L Gal,Simon Bergford et al.
Michael C Riddell et al.
Objective: Data from the Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) study were evaluated to understand glucose changes during activity and identify factors that may influence changes. ...
Observational Study
Diabetes care. 2024 Jan 1;47(1):132-139. DOI:10.2337/dc23-1548 2024
Diabetes Distress and Associations With Demographic and Clinical Variables: A Nationwide Population-Based Registry Study of 10,186 Adults With Type 1 Diabetes in Norway [0.03%]
糖尿病压力及其与人口统计学和临床变量的关系：一项关于挪威10186名1型糖尿病成人患者的全国性基于登记的流行病学研究
Ingvild Hernar,John G Cooper,Roy M Nilsen et al.
Ingvild Hernar et al.
Objective: To estimate diabetes distress prevalence and associations with demographic and clinical variables among adults with type 1 diabetes in Norway. ...
Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study [0.03%]
瑞典2型糖尿病患者外周动脉疾病的风险因素和患病率：一项基于全国登记的队列研究
Tarik Avdic,Hanne K Carlsen,Rikard Isaksson et al.
Tarik Avdic et al.
Objective: To investigate to what extent having control of peripheral artery disease (PAD) risk factors is associated with the risk of incident PAD in individuals with type 2 diabetes. ...
Emily D Parker,Janice Lin,Troy Mahoney et al.
Emily D Parker et al.
Objective: This study updates previous estimates of the economic burden of diagnosed diabetes, with calculation of the health resource use and indirect costs attributable to diabetes in 2022. ...